<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?>

<feed xmlns="http://purl.org/atom/ns#" version="0.3" xml:lang="en-US">
<link href="https://www.blogger.com/atom/19231217" rel="service.post" title="Hepatitis C Treatment Options" type="application/atom+xml"/>
<link href="https://www.blogger.com/atom/19231217" rel="service.feed" title="Hepatitis C Treatment Options" type="application/atom+xml"/>
<title mode="escaped" type="text/html">Hepatitis C Treatment Options</title>
<tagline mode="escaped" type="text/html">Hepatitis C Treatment Options Information</tagline>
<link href="http://www.about-hepatitis-c.com/hepatitis-c-treatment-options" rel="alternate" title="Hepatitis C Treatment Options" type="text/html"/>
<id>tag:blogger.com,1999:blog-19231217</id>
<modified>2006-04-12T16:57:00Z</modified>
<generator url="http://www.blogger.com/" version="6.72">Blogger</generator>
<info mode="xml" type="text/html">
<div xmlns="http://www.w3.org/1999/xhtml">This is an Atom formatted XML site feed. It is intended to be viewed in a Newsreader or syndicated to another site. Please visit the <a href="http://help.blogger.com/bin/answer.py?answer=697">Blogger Help</a> for more info.</div>
</info>
<convertLineBreaks xmlns="http://www.blogger.com/atom/ns#">true</convertLineBreaks>
<entry xmlns="http://purl.org/atom/ns#">
<link href="https://www.blogger.com/atom/19231217/114486101975644447" rel="service.edit" title="Hepatitis Still a Frustrating  (Hepatitis C Treatment Options) Foe  " type="application/atom+xml"/>
<author>
<name>Greg</name>
</author>
<issued>2006-04-12T05:55:17-07:00</issued>
<modified>2006-04-12T16:56:59Z</modified>
<created>2006-04-12T16:56:59Z</created>
<link href="http://www.about-hepatitis-c.com/hepatitis-c-treatment-options/2006/04/hepatitis-still-frustrating-hepatitis_12.html" rel="alternate" title="Hepatitis Still a Frustrating  (Hepatitis C Treatment Options) Foe  " type="text/html"/>
<id>tag:blogger.com,1999:blog-19231217.post-114486101975644447</id>
<title mode="escaped" type="text/html">Hepatitis Still a Frustrating  (Hepatitis C Treatment Options) Foe  </title>
<content type="application/xhtml+xml" xml:base="http://www.about-hepatitis-c.com/hepatitis-c-treatment-options" xml:space="preserve">
<div xmlns="http://www.w3.org/1999/xhtml">
<div xmlns="http://purl.org/atom/ns#"> <br/>
<a href="http://www.thestreet.com/_tsclsii/stocks/pharmaceuticals/10277576.html" rel="nofollow" target="_blank">Hepatitis Still a Frustrating Foe</a>
<br/>Street.Com - Since March 14, three drugmakers, Human Genome Sciences ( HGSI :Nasdaq - news - research - Cramer's Take ), Idenix Pharmaceuticals ( IDIX :Nasdaq - news - research - Cramer's Take ) and Valeant Pharmaceuticals ( VRX :NYSE - news - research - Cramer's   <br/>
<br/>
<a href="http://www.genengnews.com/news/bnitem.aspx?name=173654" rel="nofollow" target="_blank">MIGENIX to Present at BIO 2006</a>
<br/>Genetic Engineering News - VANCOUVER , BC, and SAN DIEGO , CA, April 6 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious and degenerative diseases, has been selected to present at the BIO 2006 Business Forum which   <br/>
<br/>
<a href="http://www.ahora.cu/english/SECTIONS/health/2006/marzo/23-03-06a.htm" rel="nofollow" target="_blank">Cuban Combined Therapy Against Chronic Hepatitis C </a>
<br/>Ahora.cu - A Cuban combination therapy for the treatment of chronic Hepatitis C is to be put on the market by the Heber Biotec S.A. company in Latin America, Asia, Africa, the Middle East and Europe, where this firm has registered the Heberon Alfa R (human   <br/> </div>
</div>
</content>
<draft xmlns="http://purl.org/atom-blog/ns#">false</draft>
</entry>
</feed>
